Abstract
By combining knowledge of polyamine biosynthesis and its inhibition by various analogues with that on the activity of synthetic anthraquinones, a series of six anthraquinone derivatives were synthesized. Their ability to inhibit the growth of leishmanial promastigotes in vitro was used as a preliminary screen to check their potential as new antileishmanial chemotherapeutics. They were tested against four strains, representing four different species; Leishmania tropica major, L. tropica minor, L. aethiopica and L. donovani, associated with four separate disease syndromes. All six derivatives exhibited a fair degree of antileishmanial activity, some being more effective than others. They all inactivated cultures at 100 μg/ml and some did so at 10 μg/ml and even 1μg/ml; but taking different lengths of time to achieve this. Antileishmanial activity associated with anthraquinone derivatives might provide a new approach to the chemotherapy of leishmaniasis.
| Original language | English |
|---|---|
| Pages (from-to) | 1729-1732 |
| Number of pages | 4 |
| Journal | Biochemical Pharmacology |
| Volume | 32 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Jun 1983 |
Fingerprint
Dive into the research topics of 'The effect of diaminoalkyl-anthraquinone derivatives on the growth of the promastigotes of Leishmania tropica minor, L. T. major, L. donovani and L. aethiopica'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver